<DOC>
	<DOCNO>NCT02875574</DOCNO>
	<brief_summary>The 'rising tide ' antimicrobial resistance source concern across infectious disease . In UK , example , 6.8 % ~8,500 tuberculosis patient see 2012 resistant cheap effective first-line drug isoniazid . It great importance prevent loss current anti-tuberculosis drug prevent spread resistance treat patient well possible . Currently , guidance best treatment isoniazid resistant tuberculosis inconsistent globally . Data randomise controlled trial , peak quality evidence , sparse . It thus important study use pre-existing observational data undertaken . The investigator aim use data sample collect Public Health England National Health Service hospital determine ) best treatment patient isoniazid resistant tuberculosis disease ( cohort study ) b ) different cause drug resistance infect bacteria influence ) ( nest case-control study ) . Eligible participant isoniazid resistant tuberculosis ( without associate rifampicin resistance ) England 2009 2013 notified Public Health England . The study conduct University College London , National Health Service hospital Public Health England last December 2017 . Patient hospital record disease surveillance record access cultured bacteria previously store sample sequence .</brief_summary>
	<brief_title>Improving Management Drug Resistant Tuberculosis UK</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Multidrug-Resistant</mesh_term>
	<criteria>Isoniazid resistant nonmultidrug resistant tuberculosis patient . Notified Public Health England 's Enhanced Tuberculosis Surveillance System 20092013 . Adults age 18 year . Patients treated private hospital . Nonnotified patient . Individuals site disease require 12 month treatment . Individuals diagnose postmortem .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Isoniazid</keyword>
	<keyword>Drug Resistance</keyword>
</DOC>